Previous webinars > 12th EDRA webinar 06/25/2024

12th EDRA Webinar

June 25th, 2024, from 4:00 to 5:30 pm (CET)

Dr. Anna Campalans - Keynote speaker

Institute of Cellular and Molecular Radiobiology - François Jacob - CEA, Fontenay-aux Roses, France

Repair of oxidative DNA damage in the chromatin context

Oxidative stress induces a plethora of DNA lesions, among which 8-oxoguanine (8-oxoG), a product of guanine oxidation, is the most abundant one. 8-oxoG is a highly mutagenic lesion that is repaired by the Base excision repair (BER) pathway, initiated by the recognition and excision of the modified base by the DNA glycosylase OGG1. Finding 8-oxoG in the context of nuclear architecture in which the DNA is highly compacted in chromatin is a challenging task for OGG1. Yet, the timely restoration of genome integrity is essential since inefficient clearance of oxidative lesions has been associated to multiple pathologies, including cancers as well as neurodegenerative diseases. I will present our recent discoveries concerning OGG1 dynamics in the chromatin context and discuss the potential use of OGG1 inhibitors as new promising therapeutic tools.

Dr. Tanveer Ahmad - Short talk

Institute for Advanced Biosciences, IAB, La Tronche, France

Dynamics of RNF113A methylation and its role in SCLC sensitivity to alkylation damage

Small cell lung cancer (SCLC) represents the most lethal form of lung cancer, with poor survival due in part to chemoresistance towards limited available therapeutic agents. Lysine methyltransferase SMYD3 is upregulated in SCLC. We have previously established SMYD3 as a critical regulator of SCLC sensitivity towards alkylation-based chemotherapy. SMYD3 mediated methylation of RNF113A obstructs its interaction with phosphatase PP4 and governs its phosphorylation levels. This well coordinated dialogue between posttranslational modifications plays a crucial role to endorse and preserve the E3 ligase activity of RNF113A which is essential for its function in alkylation DNA damage response. Active form of RNF113A methylated by SMYD3 leads to better activation of the ASCC damage repair pathway and promotes cellular resistance to alkylation damage. Remarkably, SMYD3 inhibition revives the sensitivity of SCLC cells to alkylating drugs and promotes sustained response to chemotherapy.
Because lysine methylation signaling is dynamic, we were interested to explore the possibility of an active RNF113A demethylation. Using in vitro demethylation assays and mass spectrometry, we identified a potential counteracting demethylase, which showed specific activity against methylated RNF113A peptides. Besides in vitro characterization of its activity, we confirmed that this demethylase down-regulates SMYD3-mediated RNF113A methylation in cells. Here, we report one of the very first example of non-histone demethylation activity by a JmjC demethylase, illustrating the dynamic regulation of RNF113A methylation with potential consequences on SCLC sensitivity to chemotherapy. Indeed, bioinformatics analysis suggests that this demethylase might be enriched in a specific SCLC subtype, indicating that some tumors might be more sensitive to alkylating therapy than others We are now assessing the consequences of RNF methylation dynamics on SCLC cell tolerance to alkylation-based DNA damage. A better understanding of the effectors at play could help to optimize the therapeutic repertoire against this deadly lung cancer.

Julio Liu (PhD student) - Short talk

Center for Protein Research, University of Copenhagen – Copenhagen, Denmark

A novel SUMO-targeted ubiquitin ligase with a key role in DNA-protein crosslink repair and other stress responses

Protein SUMOylation provides a critical driving force for cellular stress responses including DNA-protein crosslink (DPC) repair and arsenic-induced PML body degradation. In genome-scale screens, we identified the human E3 ligase TOPORS as a key effector of SUMO-dependent DPC resolution. We demonstrate that TOPORS promotes DPC repair by functioning as a SUMO-targeted ubiquitin ligase (STUbL) for DPCs, combining ubiquitin ligase activity through its RING domain with poly-SUMO chain binding via a cluster of SUMO-interacting motifs, analogous to the STUbL RNF4. Besides its crucial role in DPC repair, TOPORS makes major contributions to other cellular stress responses, namely PML bodies degradation and defective ribosomal products resolution. These major STUbL-dependent pathways are in fact driven by the parallel actions of TOPORS and RNF4, boosting efficiency of these processes. Underscoring the importance of this relationship, TOPORS and RNF4 display a strong synthetic lethal interaction in cells. These new insights reveal that the joint action of TOPORS and RNF4 represents a general mechanistic principle in fundamental cellular processes and stress responses driven by SUMO-ubiquitin crosstalk. On top of this, as we discovered USP7 regulates TOPORS, of which inhibitors are of great interests in clinical implication, it may open up an exciting avenue for improving the efficacy of current cancer treatments with DPCs-inducing ability by harnessing the translational potential.